Clinical trial
D-serine for Posttraumatic Stress Disorder Treatment
NCT00215878 · Herzog Hospital, Other · Completed
Key facts
| NCT number | NCT00215878 |
|---|---|
| Title | D-serine for Posttraumatic Stress Disorder Treatment |
| Official title | D-serine for Posttraumatic Stress Disorder Treatment |
| Lead sponsor | Herzog Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Posttraumatic Stress Disorder |
| Intervention type | Drug |
| Interventions | D-serine (~2g /day) |
| Enrollment | 22 |
| Start date | Aug 1, 2003 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 9, 2012 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: